Ticker >

Shree Ganesh BioTech share price

Shree Ganesh Bio-Tech (India) Ltd.

BSE: 539470 SECTOR: Agriculture  57k   114   14

1.11
+0.01 (0.91%)
BSE: 01 Nov 07:04 PM

Price Summary

Today's High

₹ 1.11

Today's Low

₹ 1.06

52 Week High

₹ 1.89

52 Week Low

₹ 0.74

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

44.25 Cr.

Enterprise Value

43.82 Cr.

No. of Shares

39.86 Cr.

P/E

37.12

P/B

0.7

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1.59

CASH

0.43 Cr.

DEBT

0 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  0.03

Sales Growth

-67.53%

ROE

0.99 %

ROCE

1.36%

Profit Growth

-69.55 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-67.53%
3 Year5.61%
5 Year28.14%

Profit Growth

1 Year-69.55%
3 Year25.14%
5 Year-19.09%

ROE%

1 Year0.99%
3 Year2.86%
5 Year1.91%

ROCE %

1 Year1.36%
3 Year3.9%
5 Year2.57%

Debt/Equity

0

Price to Cash Flow

4.36

Interest Cover Ratio

8550

CFO/PAT (5 Yr. Avg.)

4.46500676081252

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 0.00 0.00
Jun 2024 0.00 0.00
Mar 2024 0.00 0.00
Dec 2023 0.00 0.00
Sep 2023 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -40.94 days.
  • The company has a good cash flow management; CFO/PAT stands at 4.46500676081252.

 Limitations

  • The company has shown a poor revenue growth of 5.61203908397463% for the Past 3 years.
  • Company has a poor ROE of 2.86379821455309% over the past 3 years.
  • Company has a poor ROCE of 3.90202076374585% over the past 3 years
  • Company has high debtor days of 203.6861.
  • The company is trading at a high PE of 37.12.
  • The company is trading at a high EV/EBITDA of 36.7774.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 4.12 4.12 3.78 3.56 1.98
Total Expenditure 4.04 4.04 4.3 3.69 1.96
Operating Profit 0.08 0.09 -0.51 -0.13 0.02
Other Income 0 0 1.06 0.37 0.3
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.08 0.09 0.54 0.24 0.32
Tax 0 0 0 0 0
Profit After Tax 0.08 0.09 0.54 0.24 0.32
Adjusted EPS (Rs) 0 0 0.01 0.01 0.01

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 2.47 17.21 72.64 62.45 20.28
Total Expenditure 2.24 16.51 69.19 60.3 20.48
Operating Profit 0.24 0.71 3.45 2.15 -0.2
Other Income 0 0 0.05 0.56 1.06
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 -0.28 0 0 0
Profit Before Tax 0.24 0.43 3.5 2.71 0.85
Tax 0 0.11 0.97 0.68 0.23
Net Profit 0.24 0.32 2.53 2.04 0.62
Adjusted EPS (Rs.) 0.01 0.01 0.06 0.05 0.02

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 19.93 19.93 19.93 39.86 39.86
Total Reserves 37.54 37.86 40.39 22.49 23.12
Borrowings 0.19 0.19 0 0 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 7.05 16.64 33.24 17.17 10.64
Total Liabilities 64.72 74.63 93.55 79.52 73.62
Assets
Net Block 0 0 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 3.06 3.22 0 0
Loans & Advances 43.86 43.16 46.36 59.68 69.89
Other N/C Assets 0 0 0 0 0
Current Assets 20.85 28.41 43.97 19.84 3.73
Total Assets 64.72 74.63 93.55 79.52 73.62
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.24 0.43 3.5 2.71 0.85
Adjustment 0 0 0 0 0
Changes in Assets & Liabilities -1.25 2.05 1.04 8.5 9.54
Tax Paid 0 -0.11 -0.97 -0.68 -0.23
Operating Cash Flow -1.01 2.36 3.57 10.54 10.16
Investing Cash Flow 0.99 -2.36 -3.37 -10.09 -10.21
Financing Cash Flow 0 0 -0.19 0 0
Net Cash Flow -0.02 0.01 0.01 0.44 -0.05

Corporate Actions

Investors Details

 No Promoters Data available for this company.
Report us
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 100.00 100.00 100.00 100.00 100.00
new era fund limited 2.17 2.17 1.42 1.42 1.42
ashok kumar - 1.26 - - -
shiv corporation 3.66 - - - -
shreeji capital partners 4.04 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Shree Ganesh BioTech - Quaterly Results23 Oct 2024, 12:00PM Shree Ganesh BioTech - Quaterly Results23 Oct 2024, 12:00PM Shree Ganesh BioTech - Quaterly Results23 Oct 2024, 12:00PM Shree Ganesh BioTech - Quaterly Results13 Aug 2024, 4:23PM Shree Ganesh BioTech - Quaterly Results13 Aug 2024, 4:23PM Shree Ganesh Remedies informs about outcome of board meeting1 Jun 2024, 3:10PM Shree Ganesh BioTech - Quaterly Results13 Feb 2024, 4:49PM Shree Ganesh BioTech - Quaterly Results13 Feb 2024, 4:49PM Shree Ganesh Biotech (India) informs about revised disclosures19 Jan 2024, 1:09PM Shree Ganesh Biotech (India) informs about disclosure 19 Jan 2024, 1:03PM Shree Ganesh Biotech (India) submits certificate 22 Apr 2023, 3:57PM Shree Ganesh Biotech (India) informs about disclosure25 Feb 2023, 11:37AM Shree Ganesh Biotech (India) informs about outcome of board meeting15 Feb 2023, 2:37PM Shree Ganesh BioTech - Quaterly Results14 Feb 2023, 1:25PM Shree Ganesh Biotech (India) submits board meeting intimation 7 Feb 2023, 4:57PM Shree Ganesh BioTech - Quaterly Results9 Nov 2022, 3:57PM Shree Ganesh BioTech - Quaterly Results9 Nov 2022, 3:57PM Shree Ganesh BioTech - Quaterly Results9 Nov 2022, 3:57PM Shree Ganesh Biotech (India) informs about disclosures17 Sep 2022, 12:14PM Shree Ganesh Biotech (India) informs about outcome of board meeting 25 Jul 2022, 3:46PM Shree Ganesh BioTech - Quaterly Results25 Jul 2022, 12:11PM Shree Ganesh BioTech - Quaterly Results25 Jul 2022, 12:11PM Shree Ganesh BioTech - Quaterly Results25 Jul 2022, 12:11PM Shree Ganesh Bio-Tech (India) informs about board meeting7 Jul 2022, 9:48AM Shree Ganesh Bio-Tech (India) submits disclosure on related party transactions23 May 2022, 3:56PM Shree Ganesh Bio-Tech (India) informs about outcome of the board meeting23 May 2022, 3:53PM Shree Ganesh BioTech - Quaterly Results23 May 2022, 2:33PM Shree Ganesh BioTech - Quaterly Results23 May 2022, 2:33PM Shree Ganesh BioTech - Quaterly Results23 May 2022, 2:33PM Shree Ganesh Biotech (India) informs about disclosure27 Apr 2022, 5:09PM Shree Ganesh Biotech (India) informs about disclosure 27 Apr 2022, 10:00AM Shree Ganesh Bio-Tech (India) informs about outcome of board meeting7 Mar 2022, 4:50PM Shree Ganesh Bio-Tech (India) informs about board meeting3 Feb 2022, 10:44AM Shree Ganesh BioTech - Quaterly Results1 Feb 2022, 1:47PM Shree Ganesh BioTech - Quaterly Results1 Feb 2022, 1:47PM Shree Ganesh BioTech - Quaterly Results1 Feb 2022, 1:47PM Shree Ganesh Bio-Tech (India) informs about outcome of postal ballot notice22 Jan 2022, 3:04PM Shree Ganesh Bio-Tech (India) informs about record date29 Dec 2021, 10:07AM Shree Ganesh Biotech (India) informs about notice of postal ballot 21 Dec 2021, 4:25PM Shree Ganesh Bio-Tech informs about outcome of board meeting20 Dec 2021, 10:52AM Shree Ganesh Bio-Tech (India) informs about disclosure on related party transactions25 Jun 2021, 4:33PM Shree Ganesh Bio-Tech (India) informs about disclosure25 Jun 2021, 4:22PM Shree Ganesh Bio-Tech (India) informs about outcome of the board meeting25 Jun 2021, 4:15PM Shree Ganesh Biotech (India) informs about board meeting18 Jun 2021, 1:08PM Shree Ganesh BioTech (India) board to consider unaudited financial results 21 Oct 2020, 12:58PM Shree Ganesh BioTech India informs about updation of directors of company26 Aug 2020, 4:26PM Shree Ganesh Biotech India informs about compliance report24 Jul 2020, 3:45PM

Shree Ganesh BioTech Stock Price Analysis and Quick Research Report. Is Shree Ganesh BioTech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Shree Ganesh BioTech stock price today is Rs 1.11. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Shree Ganesh BioTech . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Shree Ganesh BioTech has a PE ratio of 37.123745819398 which is high and comparatively overvalued .

  • Share Price: - The current share price of Shree Ganesh BioTech is Rs 1.11. One can use valuation calculators of ticker to know if Shree Ganesh BioTech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Shree Ganesh BioTech has ROA of 0.8106 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Shree Ganesh BioTech has a Current ratio of 0.3505 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Shree Ganesh BioTech has a ROE of 0.9905 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Shree Ganesh BioTech has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Shree Ganesh BioTech has reported revenue growth of -67.532 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Shree Ganesh BioTech for the current financial year is -0.990250373563082 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Shree Ganesh BioTech is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Shree Ganesh BioTech is Rs 0.0299 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Shree Ganesh BioTech in Ticker for free. Also, one can get the intrinsic value of Shree Ganesh BioTech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Shree Ganesh BioTech
X